| 000 | 01661 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250511174859.0 | ||
| 264 | 0 | _c19930201 | |
| 008 | 199302s 0 0 eng d | ||
| 022 | _a0385-5600 | ||
| 024 | 7 |
_a10.1111/j.1348-0421.1992.tb02090.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMinoda, M | |
| 245 | 0 | 0 |
_aEffects of gamma-interferon and FK506 on resting B cell proliferation of New Zealand black/white F1 mice. _h[electronic resource] |
| 260 |
_bMicrobiology and immunology _c1992 |
||
| 300 |
_a885-94 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aCytotoxicity, Immunologic _xdrug effects |
| 650 | 0 | 4 |
_aDNA _ximmunology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHybridization, Genetic |
| 650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-4 _xpharmacology |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdrug therapy |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Inbred NZB |
| 650 | 0 | 4 |
_aTacrolimus _xpharmacology |
| 700 | 1 | _aOhno, M | |
| 700 | 1 | _aTomioka, Y | |
| 700 | 1 | _aHamada, K | |
| 700 | 1 | _aYamazoe, Y | |
| 700 | 1 | _aHigashikawa, M | |
| 700 | 1 | _aSugishima, H | |
| 700 | 1 | _aHigashitani, S | |
| 700 | 1 | _aFunauchi, M | |
| 700 | 1 | _aHoriuchi, A | |
| 773 | 0 |
_tMicrobiology and immunology _gvol. 36 _gno. 8 _gp. 885-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1348-0421.1992.tb02090.x _zAvailable from publisher's website |
| 999 |
_c1288728 _d1288728 |
||